orlistat with semaglutide and A Multidisciplinary Perspective on Treatment Medical Nutrition Therapy in Obesity Management Weight loss doesn't have to

An initial loss of first phase insulin response contributes to elevated postprandial plasma glucose concentrations.[3] The pathological loss of -cell function may be the result of a number of factors including -cell secretory defects, glucotoxicity due to hyperglycemia, lipotoxicity due to dislipidemia, and possibly abnormalities in secretion of, or response to, incretin hormones

The theory is that amylin is a lot more tolerable than GLP-1

How It Works: Helps muscles absorb glucose more efficiently, reducing fat storage

In vitro and in vivo studies have also shown that the rate-limiting enzyme IDO1 can be induced in epithelial cells and immune cells, with its expression regulated by inflammatory signals such as IFN-, IL-6 and TNF